个人中心 - 老虎社区

Toh_Chris

IP属地：未知

帖子 · 66帖子 · 66
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- Toh_ChrisToh_Chris
  ·2021-10-15
  $LM Funding America(LMFA)$lucky
  1,602 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-05
  Willingness to move towards the future
  非常抱歉，此主贴已删除
  1,790 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-04
  Wonder why? Increase by $75.30!! Was it a mistake 😅😆
  3,172 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Something to consider
  4,718 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Another turn.
  Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>
  WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re
  Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>
  3,803 1
  6
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Great breakthrough!
  非常抱歉，此主贴已删除
  1,663 评论
  6
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-30
  Watchful
  非常抱歉，此主贴已删除
  3,050 评论
  5
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-29
  $Red Cat Holdings Inc.(RCAT)$Why?
  1,839 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-29
  $Red Cat Holdings Inc.(RCAT)$Oh! I thought it is going up😬
  1,792 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-28
  Great!
  Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升45%</blockquote>
  Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou
  Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升45%</blockquote>
  3,213 评论
  5
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4092275556517550","uuid":"4092275556517550","gmtCreate":1629173646298,"gmtModify":1630030138393,"name":"Toh_Chris","pinyin":"tohchristohchris","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":28,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.08","exceedPercentage":"93.89%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.21","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":824691132,"gmtCreate":1634306747154,"gmtModify":1634306747383,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LMFA\">$LM Funding America(LMFA)$</a>lucky","listText":"<a href=\"https://laohu8.com/S/LMFA\">$LM Funding America(LMFA)$</a>lucky","text":"$LM Funding America(LMFA)$lucky","images":[{"img":"https://static.tigerbbs.com/f9d7dba60cb9fda231b6250e2bcb5d74","width":"750","height":"1174"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824691132","isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820737466,"gmtCreate":1633431370407,"gmtModify":1633432127496,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Willingness to move towards the future&nbsp;","listText":"Willingness to move towards the future&nbsp;","text":"Willingness to move towards the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820737466","repostId":"1133411996","repostType":4,"isVote":1,"tweetType":1,"viewCount":1790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820945712,"gmtCreate":1633346918981,"gmtModify":1633346919199,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","listText":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","text":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","images":[{"img":"https://static.tigerbbs.com/05cec00fa9d1c9f162e3e79bdb74b7d7","width":"750","height":"2201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820945712","isVote":1,"tweetType":1,"viewCount":3172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864660319,"gmtCreate":1633097994269,"gmtModify":1633130254290,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Something to consider&nbsp;","listText":"Something to consider&nbsp;","text":"Something to consider","images":[{"img":"https://static.tigerbbs.com/16fe2c6f0983c816203201c9e2466e34","width":"750","height":"2201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864660319","isVote":1,"tweetType":1,"viewCount":4718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864680840,"gmtCreate":1633097465080,"gmtModify":1633097465278,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Another turn.","listText":"Another turn.","text":"Another turn.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864680840","repostId":"1145898013","repostType":4,"repost":{"id":"1145898013","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633095114,"share":"https://www.laohu8.com/m/news/1145898013?lang=zh_CN&edition=full","pubTime":"2021-10-01 21:31","market":"us","language":"en","title":"Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145898013","media":"Tiger Newspress","summary":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re","content":"<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p><p><blockquote>华盛顿（路透社）-美国。8月份消费者支出增幅超过预期，但对7月份数据的下修保持了对第三季度经济增长放缓的预期不变，因为COVID-19感染的死灰复燃抑制了对服务的需求。</blockquote></p><p> Dow added 260 points, or 0.8%. The S&amp;P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p><p><blockquote>道琼斯指数上涨260点，涨幅0.8%。标普500和纳斯达克综合指数分别上涨0.5%和0.2%。道指成员默克公司的股票<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a>该制药商和Ridgeback Biotherapeutics表示，他们针对COVID-19的口服抗病毒治疗将轻度或中度病例患者的住院或死亡风险降低了50%，股价上涨了8%。两家公司计划寻求治疗的紧急授权。美国商务部周五表示，占美国经济活动三分之二以上的消费者支出8月份反弹0.8%，摆脱了全球半导体短缺导致的汽车销量下降的影响，半导体短缺正在削弱汽车产量。</blockquote></p><p> The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p><p><blockquote>默克公司的新药似乎提振了旅游股。皇家加勒比和拉斯维加斯金沙集团的股价在盘前交易中上涨超过1%。摩根大通上调西南航空股票评级并表示该集团大部分股票值得购买后，西南航空领涨航空股。</blockquote></p><p> The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p><p><blockquote>10年期国债收益率早盘回落至1.50%以下。随着收益率下降，以科技股为主的纳斯达克期货上涨。</blockquote></p><p> The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&amp;P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p><p><blockquote>由于通胀担忧、经济增长放缓和利率上升让投资者感到紧张，市场刚刚结束了动荡的九月。标普500本月收盘下跌4.8%，打破了七个月的连涨势头。道琼斯指数和纳斯达克综合指数分别下跌4.3%和5.3%，遭遇今年最糟糕的月份。</blockquote></p><p> “A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p><p><blockquote>高盛董事总经理Chris Hussey表示：“随着我们进入秋季和2021年第四季度，经济增长放缓、货币政策宽松程度降低、中国逆风、财政刺激减弱以及供应链瓶颈的困扰，所有这些因素共同打压了投资者的情绪。”在一份说明中说。</blockquote></p><p> Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p><p><blockquote>第二季度消费者支出以12.0%的年化增长率强劲增长，占经济6.7%增长率的大部分，这使国内生产总值水平高于2019年第四季度的峰值。第三季度的增长率预期低于5.0%。</blockquote></p><p> \"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p><p><blockquote>摩根大通基金驻纽约首席全球策略师David Kelly表示：“未来几个月，消费者势头应该会有所改善，推动经济更接近疫情后的全面复苏，并保持通胀高温。”</blockquote></p><p> Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p><p><blockquote>8月份通胀保持上升趋势。不包括波动较大的食品和能源成分的个人消费支出(PCE)价格指数继7月份上涨相同幅度后上涨0.3%。</blockquote></p><p> In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p><p><blockquote>在截至8月份的12个月中，所谓的核心PCE价格指数上涨了3.6%，与7月份的涨幅相当。</blockquote></p><p> The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p><p><blockquote>核心PCE物价指数是美联储为其灵活的2%目标而首选的通胀指标。美联储上周将今年核心PCE通胀预期从6月份的3.0%上调至3.7%。</blockquote></p><p> The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p><p><blockquote>美联储表示，最早可能在11月开始减少月度债券购买，并暗示加息可能会比预期更快。</blockquote></p><p> Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周四对立法者表示，他预计未来几个月高通胀将有所缓解。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-01 21:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p><p><blockquote>华盛顿（路透社）-美国。8月份消费者支出增幅超过预期，但对7月份数据的下修保持了对第三季度经济增长放缓的预期不变，因为COVID-19感染的死灰复燃抑制了对服务的需求。</blockquote></p><p> Dow added 260 points, or 0.8%. The S&amp;P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p><p><blockquote>道琼斯指数上涨260点，涨幅0.8%。标普500和纳斯达克综合指数分别上涨0.5%和0.2%。道指成员默克公司的股票<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a>该制药商和Ridgeback Biotherapeutics表示，他们针对COVID-19的口服抗病毒治疗将轻度或中度病例患者的住院或死亡风险降低了50%，股价上涨了8%。两家公司计划寻求治疗的紧急授权。美国商务部周五表示，占美国经济活动三分之二以上的消费者支出8月份反弹0.8%，摆脱了全球半导体短缺导致的汽车销量下降的影响，半导体短缺正在削弱汽车产量。</blockquote></p><p> The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p><p><blockquote>默克公司的新药似乎提振了旅游股。皇家加勒比和拉斯维加斯金沙集团的股价在盘前交易中上涨超过1%。摩根大通上调西南航空股票评级并表示该集团大部分股票值得购买后，西南航空领涨航空股。</blockquote></p><p> The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p><p><blockquote>10年期国债收益率早盘回落至1.50%以下。随着收益率下降，以科技股为主的纳斯达克期货上涨。</blockquote></p><p> The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&amp;P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p><p><blockquote>由于通胀担忧、经济增长放缓和利率上升让投资者感到紧张，市场刚刚结束了动荡的九月。标普500本月收盘下跌4.8%，打破了七个月的连涨势头。道琼斯指数和纳斯达克综合指数分别下跌4.3%和5.3%，遭遇今年最糟糕的月份。</blockquote></p><p> “A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p><p><blockquote>高盛董事总经理Chris Hussey表示：“随着我们进入秋季和2021年第四季度，经济增长放缓、货币政策宽松程度降低、中国逆风、财政刺激减弱以及供应链瓶颈的困扰，所有这些因素共同打压了投资者的情绪。”在一份说明中说。</blockquote></p><p> Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p><p><blockquote>第二季度消费者支出以12.0%的年化增长率强劲增长，占经济6.7%增长率的大部分，这使国内生产总值水平高于2019年第四季度的峰值。第三季度的增长率预期低于5.0%。</blockquote></p><p> \"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p><p><blockquote>摩根大通基金驻纽约首席全球策略师David Kelly表示：“未来几个月，消费者势头应该会有所改善，推动经济更接近疫情后的全面复苏，并保持通胀高温。”</blockquote></p><p> Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p><p><blockquote>8月份通胀保持上升趋势。不包括波动较大的食品和能源成分的个人消费支出(PCE)价格指数继7月份上涨相同幅度后上涨0.3%。</blockquote></p><p> In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p><p><blockquote>在截至8月份的12个月中，所谓的核心PCE价格指数上涨了3.6%，与7月份的涨幅相当。</blockquote></p><p> The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p><p><blockquote>核心PCE物价指数是美联储为其灵活的2%目标而首选的通胀指标。美联储上周将今年核心PCE通胀预期从6月份的3.0%上调至3.7%。</blockquote></p><p> The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p><p><blockquote>美联储表示，最早可能在11月开始减少月度债券购买，并暗示加息可能会比预期更快。</blockquote></p><p> Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周四对立法者表示，他预计未来几个月高通胀将有所缓解。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145898013","content_text":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.\nDow added 260 points, or 0.8%. The S&P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.Shares of Dow member Merck$(MRK)$ jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.\nThe new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.\nThe 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.\nThe market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.\n“A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.\nConsumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.\n\"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.\nInflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.\nIn the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.\nThe core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.\nThe U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.\nFed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":3803,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864616200,"gmtCreate":1633097236095,"gmtModify":1633097318428,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Great breakthrough!","listText":"Great breakthrough!","text":"Great breakthrough!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864616200","repostId":"2172968435","repostType":4,"isVote":1,"tweetType":1,"viewCount":1663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865661848,"gmtCreate":1632976715427,"gmtModify":1632976715641,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Watchful&nbsp;","listText":"Watchful&nbsp;","text":"Watchful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865661848","repostId":"1104172212","repostType":4,"isVote":1,"tweetType":1,"viewCount":3050,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865042991,"gmtCreate":1632926518068,"gmtModify":1632926518309,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Why?","listText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Why?","text":"$Red Cat Holdings Inc.(RCAT)$Why?","images":[{"img":"https://static.tigerbbs.com/c099945e824070ad62eb16c117983c94","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865042991","isVote":1,"tweetType":1,"viewCount":1839,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862155173,"gmtCreate":1632847556425,"gmtModify":1632847556534,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Oh! I thought it is going up😬","listText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Oh! I thought it is going up😬","text":"$Red Cat Holdings Inc.(RCAT)$Oh! I thought it is going up😬","images":[{"img":"https://static.tigerbbs.com/cdb0894fff3b3e2c3723a3f1c2f61b99","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862155173","isVote":1,"tweetType":1,"viewCount":1792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862989414,"gmtCreate":1632829085061,"gmtModify":1632829085132,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862989414","repostId":"1126986798","repostType":4,"repost":{"id":"1126986798","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632827257,"share":"https://www.laohu8.com/m/news/1126986798?lang=zh_CN&edition=full","pubTime":"2021-09-28 19:07","market":"us","language":"en","title":"Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升45%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1126986798","media":"Tiger Newspress","summary":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou","content":"<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p><p><blockquote>索诺玛制药公司(Sonoma Pharmaceuticals)在美国亚马逊上推出首款非处方药产品，并在欧洲亚马逊上推出一款以消费者为中心的新产品后，股价在盘前交易中飙升45%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p><p><blockquote>Sonoma Pharmaceuticals，Inc.是一家开发和生产稳定次氯酸（HOCl）产品的全球医疗保健领导者，用于伤口护理、眼部护理、鼻部护理、口腔护理和皮肤病等广泛应用，今天宣布向消费者推出Regenacyn的非处方（“OTC”）产品®高级疤痕凝胶和Ocucyn®亚马逊上的眼睑和睫毛清洁剂和MucoClyns™欧洲的亚马逊网站上。这三款产品均基于Sonoma的专利Microcyn®技术，并可立即用于客户订单。</blockquote></p><p> Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p><p><blockquote>索诺玛直接向消费者提供其卓越、安全和有效的次氯酸产品。多年来，Sonoma一直将其产品作为处方或办公室配药产品提供给医生。OTC的推出创造了直接向消费者销售的Sonoma产品的额外系列，并提供了一个直接渠道，使其经过验证的Microcyn®所有人都可以广泛使用的技术。</blockquote></p><p> Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p><p><blockquote>Regenacyn高级疤痕凝胶经临床证明可改善疤痕的整体外观，同时减轻疼痛、瘙痒、发红和炎症。Regenacyn高级疤痕凝胶保护和滋润伤口和疤痕部位，以促进更轻，更平坦和不太突出的疤痕。Regenacyn高级疤痕凝胶无毒、无刺激、无致敏。</blockquote></p><p> Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p><p><blockquote>Ocucyn眼睑和睫毛清洁剂专为日常使用而设计，是一种安全、温和、有效的眼睑和睫毛卫生解决方案。Ocucyn眼睑和睫毛清洁剂有助于清洁肮脏和结痂受刺激的眼睑。Ocucyn眼睑和睫毛清洁剂不含类固醇，无刺激性，无细胞毒性，无致敏性，不需要特殊处理。</blockquote></p><p> MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p><p><blockquote>MucoClyns是一种用于面部和皮肤的个人去污解决方案。MucoClyns可安全用于粘膜、割伤、擦伤、烧伤和体表，以便在意外暴露于感染风险后立即清洁和治疗。MucoClyns对于其指定用途具有生物相容性，并且对人类皮肤安全无刺激性。</blockquote></p><p> <b>About Sonoma Pharmaceuticals, Inc.</b></p><p><blockquote><b>关于索诺玛制药公司。</b></blockquote></p><p> Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p><p><blockquote>Sonoma Pharmaceuticals是全球医疗保健领导者，致力于开发和生产稳定的次氯酸（HOCl）产品，应用广泛，包括伤口护理、动物保健、眼部护理、鼻部护理、口腔护理、消毒剂使用和皮肤病。该公司的产品以安全有效的方式减少感染、瘙痒、疼痛、疤痕和有害的炎症反应。次氯酸（HOCl）的体外和临床研究表明，它具有令人印象深刻的止痒、抗菌、抗病毒和抗炎特性。Sonoma的稳定HOCl可立即缓解瘙痒和疼痛，杀死病原体并分解生物膜，不会刺痛或刺激皮肤，并为治疗区域的细胞充氧，帮助身体进行自然愈合过程。该公司的产品直接或通过全球54个国家的合作伙伴销售，该公司正在积极寻找新的分销合作伙伴。该公司的主要办事处位于佐治亚州伍德斯托克，在拉丁美洲设有制造业务。欧洲营销和销售总部位于荷兰鲁尔蒙德。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升45%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升45%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-28 19:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p><p><blockquote>索诺玛制药公司(Sonoma Pharmaceuticals)在美国亚马逊上推出首款非处方药产品，并在欧洲亚马逊上推出一款以消费者为中心的新产品后，股价在盘前交易中飙升45%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p><p><blockquote>Sonoma Pharmaceuticals，Inc.是一家开发和生产稳定次氯酸（HOCl）产品的全球医疗保健领导者，用于伤口护理、眼部护理、鼻部护理、口腔护理和皮肤病等广泛应用，今天宣布向消费者推出Regenacyn的非处方（“OTC”）产品®高级疤痕凝胶和Ocucyn®亚马逊上的眼睑和睫毛清洁剂和MucoClyns™欧洲的亚马逊网站上。这三款产品均基于Sonoma的专利Microcyn®技术，并可立即用于客户订单。</blockquote></p><p> Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p><p><blockquote>索诺玛直接向消费者提供其卓越、安全和有效的次氯酸产品。多年来，Sonoma一直将其产品作为处方或办公室配药产品提供给医生。OTC的推出创造了直接向消费者销售的Sonoma产品的额外系列，并提供了一个直接渠道，使其经过验证的Microcyn®所有人都可以广泛使用的技术。</blockquote></p><p> Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p><p><blockquote>Regenacyn高级疤痕凝胶经临床证明可改善疤痕的整体外观，同时减轻疼痛、瘙痒、发红和炎症。Regenacyn高级疤痕凝胶保护和滋润伤口和疤痕部位，以促进更轻，更平坦和不太突出的疤痕。Regenacyn高级疤痕凝胶无毒、无刺激、无致敏。</blockquote></p><p> Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p><p><blockquote>Ocucyn眼睑和睫毛清洁剂专为日常使用而设计，是一种安全、温和、有效的眼睑和睫毛卫生解决方案。Ocucyn眼睑和睫毛清洁剂有助于清洁肮脏和结痂受刺激的眼睑。Ocucyn眼睑和睫毛清洁剂不含类固醇，无刺激性，无细胞毒性，无致敏性，不需要特殊处理。</blockquote></p><p> MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p><p><blockquote>MucoClyns是一种用于面部和皮肤的个人去污解决方案。MucoClyns可安全用于粘膜、割伤、擦伤、烧伤和体表，以便在意外暴露于感染风险后立即清洁和治疗。MucoClyns对于其指定用途具有生物相容性，并且对人类皮肤安全无刺激性。</blockquote></p><p> <b>About Sonoma Pharmaceuticals, Inc.</b></p><p><blockquote><b>关于索诺玛制药公司。</b></blockquote></p><p> Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p><p><blockquote>Sonoma Pharmaceuticals是全球医疗保健领导者，致力于开发和生产稳定的次氯酸（HOCl）产品，应用广泛，包括伤口护理、动物保健、眼部护理、鼻部护理、口腔护理、消毒剂使用和皮肤病。该公司的产品以安全有效的方式减少感染、瘙痒、疼痛、疤痕和有害的炎症反应。次氯酸（HOCl）的体外和临床研究表明，它具有令人印象深刻的止痒、抗菌、抗病毒和抗炎特性。Sonoma的稳定HOCl可立即缓解瘙痒和疼痛，杀死病原体并分解生物膜，不会刺痛或刺激皮肤，并为治疗区域的细胞充氧，帮助身体进行自然愈合过程。该公司的产品直接或通过全球54个国家的合作伙伴销售，该公司正在积极寻找新的分销合作伙伴。该公司的主要办事处位于佐治亚州伍德斯托克，在拉丁美洲设有制造业务。欧洲营销和销售总部位于荷兰鲁尔蒙德。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOA":"Sonoma Pharmaceuticals, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126986798","content_text":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.\n\nSonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.\nSonoma offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.\nRegenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.\nOcucyn Eyelid & Eyelash Cleanser, designed for everyday use, is a safe, gentle & effective solution for good eyelid & eyelash hygiene. Ocucyn Eyelid & Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid & Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.\nMucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.\nAbout Sonoma Pharmaceuticals, Inc.\nSonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.","news_type":1,"symbols_score_info":{"SNOA":0.9}},"isVote":1,"tweetType":1,"viewCount":3213,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}